Equity grants to Vireo Growth (VREOF) director in new Form 4

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Vireo Growth Inc. director Hussey Ross Michael reported equity-based compensation grants on May 15, 2026. He received 80,000 restricted stock units and a separate grant of 96,859 restricted stock units, each tied to one subordinate voting share per unit.

He also received stock options over 95,310 subordinate voting shares and another option grant over 115,506 shares, with an exercise price of 0.424 per share and expiration on May 14, 2036. The footnotes state that both RSUs and options vest in three equal annual portions, beginning on the grant date and continuing through March 31, 2028, with RSUs settling in cash, shares, or a mix after vesting.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Hussey Ross Michael

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock options (right to buy)	115,506	$0.00	--
Grant/Award	Restricted stock units	96,859	$0.00	--
Grant/Award	Stock options (right to buy)	95,310	$0.00	--
Grant/Award	Restricted stock units	80,000	$0.00	--

Holdings After Transaction: Stock options (right to buy) — 115,506 shares (Direct, null); Restricted stock units — 96,859 shares (Direct, null)

Footnotes (1)

Each stock option vests on the following schedule: one-third (1/3) of the options vest on the grant date, one-third (1/3) vest on March 31, 2027 and the remaining one-third (1/3) vest on March 31, 2028. Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. The RSUs vest on the following schedule: one-third (1/3) of the RSUs vest on the grant date, one-third (1/3) vest on March 31, 2027 and the remaining one-third (1/3) vest on March 31, 2028. Vested RSUs settle in cash, subordinate voting shares, or a combination of both as soon as practicable (but not more than 30 days) following the date upon which the RSUs become vested. Each stock option vests in equal annual tranches over a three-year period commencing on the date of grant.

Key Figures

RSU grant 1: 80,000 units RSU grant 2: 96,859 units Option grant 1: 95,310 options +4 more

7 metrics

RSU grant 1 80,000 units Restricted stock units granted May 15, 2026

RSU grant 2 96,859 units Restricted stock units granted May 15, 2026

Option grant 1 95,310 options Stock options granted May 15, 2026

Option grant 2 115,506 options Stock options granted May 15, 2026

Option exercise price 0.424 per share Exercise price for both option grants

Option expiration May 14, 2036 Expiration date for both option grants

RSU vesting completion March 31, 2028 Final vesting date for RSU schedule

Key Terms

Restricted stock units, Subordinate voting shares, Stock options (right to buy), vesting

4 terms

Restricted stock units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Subordinate voting shares financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share."

Subordinate voting shares are a type of company stock that typically carry fewer voting rights than regular shares, meaning holders have less influence over company decisions. They are often used to raise capital while allowing founders or main shareholders to retain control. For investors, understanding the difference helps assess their level of influence in company decisions and the potential risks or benefits of holding different types of shares.

Stock options (right to buy) financial

"Stock options (right to buy) with an exercise price of 0.424 per share."

vesting financial

"one-third (1/3) of the options vest on the grant date, one-third vest on March 31, 2027 and the remaining one-third vest on March 31, 2028."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 Insider Transactions: What Each Field Means →

05/19/2026 - 04:06 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hussey Ross Michael

(Last)

(First)

(Middle)

C/O VIREO GROWTH INC.

207 SOUTH 9TH STREET

(Street)

MINNEAPOLIS

MINNESOTA

55402

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vireo Growth Inc. [ VREOF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock options (right to buy)	$0.424	05/15/2026		A		115,506		⁽¹⁾	05/14/2036	Subordinate voting shares	115,506	$0	115,506	D
Restricted stock units	⁽²⁾	05/15/2026		A		96,859		⁽³⁾	⁽³⁾	Subordinate voting shares	96,859	$0	96,859	D
Stock options (right to buy)	$0.424	05/15/2026		A		95,310		⁽⁴⁾	05/14/2036	Subordinate voting shares	95,310	$0	95,310	D
Restricted stock units	⁽²⁾	05/15/2026		A		80,000		⁽³⁾	⁽³⁾	Subordinate voting shares	80,000	$0	80,000	D

Explanation of Responses:

1. Each stock option vests on the following schedule: one-third (1/3) of the options vest on the grant date, one-third (1/3) vest on March 31, 2027 and the remaining one-third (1/3) vest on March 31, 2028.

2. Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share.

3. The RSUs vest on the following schedule: one-third (1/3) of the RSUs vest on the grant date, one-third (1/3) vest on March 31, 2027 and the remaining one-third (1/3) vest on March 31, 2028. Vested RSUs settle in cash, subordinate voting shares, or a combination of both as soon as practicable (but not more than 30 days) following the date upon which the RSUs become vested.

4. Each stock option vests in equal annual tranches over a three-year period commencing on the date of grant.

	/s/ Nicole A. Edmonds, Attorney-in-Fact for Ross Hussey	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did Vireo Growth (VREOF) director Hussey Ross Michael receive?

He received grants of restricted stock units and stock options on May 15, 2026. The awards cover 80,000 and 96,859 RSUs plus 95,310 and 115,506 options, all tied to Vireo Growth subordinate voting shares.

How do the restricted stock units granted to the Vireo Growth director vest?

The RSUs vest in three equal stages: one-third on the grant date, one-third on March 31, 2027, and the final third on March 31, 2028. After vesting, RSUs settle in cash, subordinate voting shares, or a combination of both.

What are the key terms of the stock options granted by Vireo Growth (VREOF)?

The options cover 95,310 and 115,506 subordinate voting shares at an exercise price of 0.424 per share. They vest in equal annual tranches over three years starting from the grant date and expire on May 14, 2036.

Do these Form 4 transactions mean the Vireo Growth director bought or sold shares in the market?

No, the filing reports compensation-related grants, not open-market trades. All four transactions are coded as awards or other acquisitions, reflecting new RSU and stock option grants rather than discretionary buying or selling.

What does each Vireo Growth RSU represent for the reporting director?

Each restricted stock unit represents a contingent right to receive one subordinate voting share. Once vested, each RSU can be settled in cash, shares, or a combination, as soon as practicable within 30 days after vesting.